Original language | English |
---|---|
Pages (from-to) | 45-46 |
Number of pages | 2 |
Journal | EJC Supplements |
Volume | 8 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2010 |
Anti-tumor activity of CXR1002, a novel anti-cancer clinical phase compound that induces ER stress and inhibits PIM kinases: Human tumor xenograft efficacy and in vitro mode of action
A. Barnett, S. Ding, C. Murray, M. Chamberlain, S. Plummer, T. R. J. Evans, I. MacPherson, D. Bissett, C. R. Elcombe, C. R. Wolf
Research output: Contribution to journal › Book/Film/Article review › peer-review